🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The single patient (n-of-1) randomized trial is an underused approach to re...
Status
Completed
Location
The University of Texas Health Science Center at Houston
Start Date
2018-04-02
Trial ID
NCT03461003
Treatments Being Tested
In patients naive to treatment or after a 2-week washout period for patient...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00890591
Treatments Being Tested
The project will be pursued in our respiratory, autonomic nervous system ph...
Status
Recruiting
Location
RWTH Aachen University
Start Date
2022-05-10
Trial ID
NCT04849806
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blocker v...
Status
Completed
Location
Department of Internal Medicine,Dong-A University College of Medicine
Start Date
2007-11
Trial ID
NCT01340326
Treatments Being Tested
The primary hypothesis is that titration of ACE inhibitor and Angiotensin R...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2007-03
Trial ID
NCT00446862
This study is intended to investigate the effect of angiotensin receptor bl...
Status
Recruiting
Location
CRIUCPQ
Start Date
2020-02-01
Trial ID
NCT04913870
Treatments Being Tested
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial teste...
Status
Completed
Location
Multiple Locations
Start Date
1997-09-27
Trial ID
NCT06395194
Treatments Being Tested
The renin angiotensin system (RAS) plays an important physiological and pat...
Status
Completed
Location
National Heart, Lung and Blood Institute (NHLBI)
Start Date
1997-07
Trial ID
NCT00001629
Treatments Being Tested
In children with chronic kidney disease, progression to end-stage renal fai...
Status
Completed
Location
University Hospital Motol, 1st Department of Pediatrics
Start Date
1998-01
Trial ID
NCT00221845
Treatments Being Tested
DMX-200 (repagermanium) is a C-C chemokine receptor type 2 (CCR2) inhibitor...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-05-30
Trial ID
NCT05183646